Ischemia-reperfusion injury of the retina is linked to necroptosis via the ERK1/2-RIP3 pathway

Molecular Vision

Volumn 20, Issue , 2014, Pages 1374-1387

  Gao, Sheng ^a,b   Andreeva, Kalina ^b   Cooper, Nigel G F ^b  

^a SICHUAN UNIVERSITY   (China)

^b University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ADVANCED GLYCATION END PRODUCT RECEPTOR; CELL PROTEIN; FLICE INHIBITORY PROTEIN; ISOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN RIP3; UNCLASSIFIED DRUG; 1,3 BUTADIENE DERIVATIVE; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; IMMUNOGLOBULIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 3; NITRILE; PROTEIN KINASE INHIBITOR; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE; RECEPTOR-INTERACTING PROTEIN 3, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL SURVIVAL; CELLULAR DISTRIBUTION; ENZYME ACTIVATION; FEMALE; IMMUNOHISTOCHEMISTRY; LONG EVANS RAT; NECROPTOSIS; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; RAT; REPERFUSION INJURY; RETINA GANGLION CELL; RETINA INJURY; RETINA ISCHEMIA; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY;

ANIMALS; BUTADIENES; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CELL DEATH; FEMALE; GENE EXPRESSION REGULATION; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NITRILES; PROTEIN ISOFORMS; PROTEIN KINASE INHIBITORS; RATS; RATS, LONG-EVANS; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASES; RECEPTORS, IMMUNOLOGIC; REPERFUSION INJURY; RETINAL GANGLION CELLS; SIGNAL TRANSDUCTION;

EID: 84908668461     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Osborne NN, Casson RJ, Wood JP, Chidlow G, Graham M, Melena J. Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog Retin Eye Res 2004; 23: 91-147. [PMID: 14 76 6 318].
2. Yokota H, Narayanan SP, Zhang W, Liu H, Rojas M, Xu Z, Lemtalsi T, Nagaoka T, Yoshida A, Brooks SE, Caldwell RW, Caldwell RB. Neuroprotection from retinal ischemia/reper-fusion injury by NOX2 NADPH oxidase deletion. Invest Ophthalmol Vis Sci 2011; 52:8123-31. [PMID: 21917939].
3. Anderson DR, Davis EB. Sensitivities of ocular tissues to acute pressure-induced ischemia. Arch Ophthalmol 1975; 93:267-74. [PMID: 8 0 4301].
4. Nucci C, Tartaglione R, Rombola L, Morrone LA, Fazzi E, Bagetta G. Neurochemical evidence to implicate elevated glutamate in the mechanisms of high intraocular pressure (IOP)-induced retinal ganglion cell death in rat. Neurotoxi-cology 2005; 26:935-41. [PMID: 16126273].
5. Fujita R, Ueda M, Fujiwara K, Ueda H. Prothymosin-alpha plays a defensive role in retinal ischemia through necrosis and apoptosis inhibition. Cell Death Differ 2009; 16:349-58. [PMID: 18989338].
6. Vanden Berghe T, Linkermann A, Jouan-Lanhouet S, Walczak H, Vandenabeele P. Regulated necrosis: the expanding network of non-apoptotic cell death pathways. Nat Rev Mol Cell Biol 2014; 15:135-47. [PMID: 24452471].
7. Takahashi N, Duprez L, Grootjans S, Cauwels A, Nerinckx W, DuHadaway JB, Goossens V, Roelandt R, Van Hauwer-meiren F, Libert C, Declercq W, Callewaert N, Prendergast GC, Degterev A, Yuan J, Vandenabeele P. Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models. Cell Death Dis 2012; 3:e437 [PMID: 23190609].
8. Chang GQ, Hao Y, Wong F. Apoptosis: final common pathway of photoreceptor death in rd, rds, and rhodopsin mutant mice. Neuron 1993; 11:595-605. [PMID: 8398150].
9. Sancho-Pelluz J, Arango-Gonzalez B, Kustermann S, Romero FJ, van Veen T, Zrenner E, Ekstrom P, Paquet-Durand F. Photoreceptor cell death mechanisms in inherited retinal degeneration. Mol Neurobiol 2008; 38:253-69. [PMID: 18982459].
10. Guo L, Moss SE, Alexander RA, Ali RR, Fitzke FW, Cordeiro MF. Retinal ganglion cell apoptosis in glaucoma is related to intraocular pressure and IOP-induced effects on extracellular matrix. Invest Ophthalmol Vis Sci 2005; 46:175-82. [PMID: 15623771].
11. Bonfoco E, Krainc D, Ankarcrona M, Nicotera P, Lipton SA. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci USA 1995; 92:7162-6. [PMID: 7638161].
12. Trichonas G, Murakami Y, Thanos A, Morizane Y, Kayama M, Debouck CM, Hisatomi T, Miller JW, Vavvas DG. Receptor interacting protein kinases mediate retinal detachment-induced photoreceptor necrosis and compensate for inhibition of apoptosis. Proc Natl Acad Sci USA 2010; 107:21695-700. [PMID: 21098270].
13. Hanus J, Zhang H, Wang Z, Liu Q, Zhou Q, Wang S. Induction of necrotic cell death by oxidative stress in retinal pigment epithelial cells. Cell Death Dis 2013; 4:e965 [PMID: 24336085].
14. Sato K, Li S, Gordon WC, He J, Liou GI, Hill JM, Travis GH, Bazan NG, Jin M. Receptor interacting protein kinase-mediated necrosis contributes to cone and rod photoreceptor degeneration in the retina lacking interphotoreceptor retinoid-binding protein. J Neurosci 2013; 33:17458-68. [PMID: 2 4174 679].
15. Dvoriantchikova G, Degterev A, Ivanov D. Retinal ganglion cell (RGC) programmed necrosis contributes to ischemia-reperfusion-induced retinal damage. Exp Eye Res 2014; 123:1-7. [PMID: 2 4751757].
16. Rosenbaum DM, Degterev A, David J, Rosenbaum PS, Roth S, Grotta JC, Cuny GD, Yuan J, Savitz SI. Necroptosis, a novel form of caspase-independent cell death, contributes to neuronal damage in a retinal ischemia-reperfusion injury model. J Neurosci Res 2010; 88:1569-76. [PMID: 20025059].
17. Kaczmarek A, Vandenabeele P, Krysko DV. Necroptosis: the release of damage-associated molecular patterns and its physiological relevance. Immunity 2013; 38:209-23. [PMID: 23438821].
18. Cho YS, Challa S, Moquin D, Genga R, Ray TD, Guildford M, Chan FKM. Phosphorylation-Driven Assembly of the RIP1–RIP3 Complex Regulates Programmed Necrosis and Virus-Induced Inflammation. Cell 2009; 137:1112-23. [PMID: 19524513].
19. Vandenabeele P, Galluzzi L, Vanden Berghe T, Kroemer G. Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol 2010; 11:700-14. [PMID: 20823910].
20. Long JS, Ryan KM. New frontiers in promoting tumour cell death: targeting apoptosis, necroptosis and autophagy. Onco-gene 2012; 31:5045-60. [PMID: 2 2 310 28 4].
21. Viringipurampeer IA, Shan X, Gregory-Evans K, Zhang JP, Mohammadi Z, Gregory-Evans CY. Rip3 knockdown rescues photoreceptor cell death in blind pde6c zebrafish. Cell Death Differ 2014; 21:665-75. [PMID: 2 4 413151].
22. Murakami Y, Matsumoto H, Roh M, Giani A, Kataoka K, Morizane Y, Kayama M, Thanos A, Nakatake S, Notomi S, Hisatomi T, Ikeda Y, Ishibashi T, Connor KM, Miller JW, Vavvas DG. Programmed necrosis, not apoptosis, is a key mediator of cell loss and DAMP-mediated inflammation in dsRNA-induced retinal degeneration. Cell Death Differ 2014; 21:270-7. [PMID: 2 3 9 5 4 8 61].
23. Pouwels SD, Heijink IH, Ten Hacken NH, Vandenabeele P, Krysko DV, Nawijn MC, van Oosterhout AJ. DAMPs activating innate and adaptive immune responses in COPD. Mucosal Immunol 2014; 7:215-26. [PMID: 24150257].
24. Muhammad S, Barakat W, Stoyanov S, Murikinati S, Yang H, Tracey KJ, Bendszus M, Rossetti G, Nawroth PP, Bierhaus A, Schwaninger M. The HMGB1 receptor RAGE mediates ischemic brain damage. J Neurosci 2008; 28:12023-31. [PMID: 19005067].
25. Dvoriantchikova G, Hernandez E, Grant J, Santos AR, Yang H, Ivanov D. The high-mobility group box-1 nuclear factor mediates retinal injury after ischemia reperfusion. Invest Ophthalmol Vis Sci 2011; 52:7187-94. [PMID: 21828158].
26. Zitvogel L, Kepp O, Kroemer G. Decoding cell death signals in inflammation and immunity. Cell 2010; 140:798-804. [PMID: 20303871].
27. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002; 418:191-5. [PMID: 12110 89 0].
28. van Beijnum JR, Buurman WA, Griffioen AW. Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1). Angiogenesis 2008; 11:91-9. [PMID: 1826 4787].
29. Sims GP, Rowe DC, Rietdijk ST, Herbst R, Coyle AJ. HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol 2010; 28:367-88. [PMID: 20192808].
30. Dvoriantchikova G, Hernandez E, Grant J, Santos ARC, Yang H, Ivanov D. The High-Mobility Group Box-1 Nuclear Factor Mediates Retinal Injury after Ischemia Reperfusion. Invest Ophthalmol Vis Sci 2011; 52:7187-94. [PMID: 21828158].
31. Hassid BG, Nair MN, Ducruet AF, Otten ML, Komotar RJ, Pinsky DJ, Schmidt AM, Yan SF, Connolly ES. Neuronal RAGE expression modulates severity of injury following transient focal cerebral ischemia. J Clin Neurosci 2009; 16:302-6. [PMID: 19071026].
32. Kalea AZ, Reiniger N, Yang H, Arriero M, Schmidt AM, Hudson BI. Alternative splicing of the murine receptor for advanced glycation end-products (RAGE) gene. FASEB J 2009; 23:1766-74. [PMID: 19164451].
33. Koch M, Chitayat S, Dattilo BM, Schiefner A, Diez J, Chazin WJ, Fritz G. Structural basis for ligand recognition and activation of RAGE. Structure 2010; 18:1342-52. [PMID: 20947022].
34. Zong H, Madden A, Ward M, Mooney MH, Elliott CT, Stitt AW. Homodimerization is essential for the receptor for advanced glycation end products (RAGE)-mediated signal transduction. J Biol Chem 2010; 285:23137-46. [PMID: 20504772].
35. Marinakis E, Bagkos G, Piperi C, Roussou P, Diamanti-Kandarakis E. Critical role of RAGE in lung physiology and tumorigenesis: a potential target of therapeutic intervention? Clin Chem Lab Med 2014; 52:189-200. [PMID: 24108211].
36. Sparvero LJ, Asafu-Adjei D, Kang R, Tang DL, Amin N, Im J, Rutledge R, Lin B, Amoscato AA, Zeh HJ, Lotze MT. RAGE (Receptor for Advanced Glycation Endproducts), RAGE Ligands, and their role in Cancer and Inflammation. J Transl Med 2009; 7:7 [PMID: 19146667].
37. Huskens D, Princen K, Schreiber M, Schols D. The role of N-glycosylation sites on the CXCR4 receptor for CXCL-12 binding and signaling and X4 HIV-1 viral infectivity. Virology 2007; 363:280-7. [PMID: 17331556].
38. Arey BJ. The Role of Glycosylation in Receptor Signaling. In: Petrescu DS, ed.: InTech, 2012.
39. Yan X, Han J, Zhang Z, Wang J, Cheng Q, Gao K, Ni Y, Wang Y. Lung cancer A549 cells migrate directionally in DC electric fields with polarized and activated EGFRs. Bioelectro-magnetics 2009; 30:29-35. [PMID: 18618607].
40. Laberge M. Intrinsic protein electric fields: basic non-covalent interactions and relationship to protein-induced Stark effects. Biochim Biophys Acta 1998; 1386:305-30. [PMID: 9733989].
41. Solá RJ, Griebenow K. Effects of glycosylation on the stability of protein pharmaceuticals. J Pharm Sci 2009; 98:1223-45. [PMID: 18661536].
42. Srikrishna G, Huttunen HJ, Johansson L, Weigle B, Yamaguchi Y, Rauvala H, Freeze HH. N-Glycans on the receptor for advanced glycation end products influence amphoterin binding and neurite outgrowth. J Neurochem 2002; 80:998-1008. [PMID: 11953 45 0].
43. Zhang Z, Qin X, Tong N, Zhao X, Gong Y, Shi Y, Wu X. Valproic acid-mediated neuroprotection in retinal ischemia injury via histone deacetylase inhibition and transcriptional activation. Exp Eye Res 2012; 94:98-108. [PMID: 221430 29].
44. Ha HC, Snyder SH. Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc Natl Acad Sci USA 1999; 96:13978-82. [PMID: 10570184].
45. Xu Y, Huang S, Liu ZG, Han JH. Poly(ADP-ribose) polymerase-1 signaling to mitochondria in necrotic cell death requires RIP1/TRAF2-mediated JNK1 activation. J Biol Chem 2006; 281:8788-95. [PMID: 16 4 4 6354].
46. Zhang M, Li J, Geng R, Ge W, Zhou Y, Zhang C, Cheng Y, Geng D. The inhibition of ERK activation mediates the protection of necrostatin-1 on glutamate toxicity in HT-22 cells. Neurotox Res 2013; 24:64-70. [PMID: 23307752].
47. Moriwaki K, Chan FK. RIP3: a molecular switch for necrosis and inflammation. Genes Dev 2013; 27:1640-9. [PMID: 23913919].
48. Gong J, Kumar SA, Graham G, Kumar AP. FLIP: Molecular Switch Between Apoptosis and Necroptosis. Mol Carcinog 2014; 53:675-85. [PMID: 23625539].
49. Galvao J, Davis B, Tilley M, Normando E, Duchen MR, Cordeiro MF. Unexpected low-dose toxicity of the universal solvent DMSO. FASEB J 2014; 28:1317-30. [PMID: 24327606].
50. Shi M, Kumar SR, Motajo O, Kretschmer F, Mu X, Badea TC. Genetic interactions between Brn3 transcription factors in retinal ganglion cell type specification. PLoS ONE 2013; 8:E76347 [PMID: 2411610 3].
51. Rai V, Maldonado AY, Burz DS, Reverdatto S, Yan SF, Schmidt AM, Shekhtman A. Signal transduction in receptor for advanced glycation end products (RAGE): solution structure of C-terminal rage (ctRAGE) and its binding to mDia1. J Biol Chem 2012; 287:5133-44. [PMID: 22194616].
52. Sakaguchi M, Murata H, Yamamoto K, Ono T, Sakaguchi Y, Motoyama A, Hibino T, Kataoka K, Huh NH. TIRAP, an adaptor protein for TLR2/4, transduces a signal from RAGE phosphorylated upon ligand binding. PLoS ONE 2011; 6: e23132 [PMID: 218 29 70 4].
53. Ishihara K, Tsutsumi K, Kawane S, Nakajima M, Kasaoka T. The receptor for advanced glycation end-products (RAGE) directly binds to ERK by a D-domain-like docking site. FEBS Lett 2003; 550:107-13. [PMID: 12935895].
54. Borsi V, Cerofolini L, Fragai M, Luchinat C. NMR characterization of the C-terminal tail of full-length RAGE in a membrane mimicking environment. J Biomol NMR 2012; 54:285-90. [PMID: 23001324].
55. Mizumoto S, Takahashi J, Sugahara K. Receptor for Advanced Glycation End Products (RAGE) Functions as Receptor for Specific Sulfated Glycosaminoglycans, and Anti-RAGE Antibody or Sulfated Glycosaminoglycans Delivered in Vivo Inhibit Pulmonary Metastasis of Tumor Cells. J Biol Chem 2012; 287:18985-94. [PMID: 22493510].
56. Bowman MA, Schmidt AM. The next generation of RAGE modulators: implications for soluble RAGE therapies in vascular inflammation. J Mol Med (Berl) 2013.
57. Tae HJ, Kim JM, Park S, Tomiya N, Li G, Wei W, Petrashevs-kaya N, Ahmet I, Pang J, Cruschwitz S, Riebe RA, Zhang Y, Morrell CH, Browe D, Lee YC, Xiao RP, Talan MI, Lakatta EG, Lin L. The N-glycoform of sRAGE is the key determinant for its therapeutic efficacy to attenuate injury-elicited arterial inflammation and neointimal growth. J Mol Med (Be rl) 2013.
58. Ha CH, Kim S, Chung J, An SH, Park S, Choi D, Kwon K. Inhibitory effect of soluble RAGE in disturbed flow-induced atherogenesis. Int J Mol Med 2013; 32:373-80. [PMID: 23708564].
59. Gesslein B, Hakansson G, Carpio R, Gustafsson L, Perez MT, Malmsjo M. Mitogen-activated protein kinases in the porcine retinal arteries and neuroretina following retinal ischemia-reperfusion. Mol Vis 2010; 16:392-407. [PMID: 20300568].
60. Zhang D, Lin J, Han J. Receptor-interacting protein (RIP) kinase family. Cell Mol Immunol 2010; 7:243-9. [PMID: 20 383176].
61. WesterAssay I–C. Complete Sample Protocol for Measuring IC50 of Inhibitor U0126 in NIH3T3 Responding to Acidic Fibroblast Growth Factor (aFGF-1). 2012.
62. Cho YS, Challa S, Moquin D, Genga R, Ray TD, Guildford M, Chan FK. Phosphorylation-driven assembly of the RIP1– RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 2009; 137:1112-23. [PMID: 19524513].
63. He S, Wang L, Miao L, Wang T, Du F, Zhao L, Wang X. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell 2009; 137:1100-11. [PMID: 19524512].
64. Zhang DW, Shao J, Lin J, Zhang N, Lu BJ, Lin SC, Dong MQ, Han J. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 2009; 325:332-6. [PMID: 19498109].
65. Safa AR, Pollok KE. Targeting the Anti-Apoptotic Protein c-FLIP for Cancer Therapy. Cancers 2011; 3:1639-71. [PMID: 22348197].
66. Shirley S, Micheau O. Targeting c-FLIP in cancer. Cancer Lett 2013; 332:141-50. [PMID: 210 71136].